Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Dexamethasone for Preventing Post Operative Nausea and Vomiting in Total Abdominal Hysterectomy
TCTR20230410007Phase 1Completed
- Sponsor
- Khon Kaen Hospital Institutional Review Board
- Start
- Aug 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postoperative nausea and vomiting (PONV) comparing Intravenous dexamethasone with Placebo / control (2 arms). Primary endpoint: Incidence of postoperative nausea and vomiting. Started Aug 2022; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on TCTR20230410007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230410007.